Insiders Incyte Corporation

Stocks

INCY

US45337C1027

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 18:54:03 08/06/2026 BST			5-day change	1st Jan Change
99.96 ^USD	-2.36%		+3.52%	+0.18%

03:32pm	Incyte To Acquire Vega Therapeutics For Up To $2 Billion	MT
03:25pm	Incyte Corporation, Vega Therapeutics, Inc. - M&A Call

Insiders

05-21	Incyte Insider Sold Shares Worth $1,423,950, According to a Recent SEC Filing	MT
04-28	Incyte Appoints Suketu Upadhyay as Executive Vice President, Effective May 4, 2026	CI
04-21	Incyte Insider Sold Shares Worth $1,801,366, According to a Recent SEC Filing	MT
03-30	Incyte Corporation Announces Resignation of Susanne Schaffert from the Board of Directors, Effective April 15, 2026	CI
03-25	Incyte Corporation Announces Executive Changes	CI
01-08	Incyte Insider Sold Shares Worth $1,184,064, According to a Recent SEC Filing	MT
12-12	Incyte Insider Sold Shares Worth $554,965, According to a Recent SEC Filing	MT
12-12	Incyte Corporation Announces Resignation of Hervé Hoppenot from Board of Directors, Effective December 12, 2025	CI
12-01	Incyte appoints Richard Hoffman as executive vice president and general counsel	RE
12-01	Incyte Corporation Announces Executive Changes	CI
11-07	Incyte Insider Sold Shares Worth $534,813, According to a Recent SEC Filing	MT
11-05	Incyte Insider Sold Shares Worth $289,017, According to a Recent SEC Filing	MT
06/10/25	Incyte Insider Sold Shares Worth $351,978, According to a Recent SEC Filing	MT
06/10/25	Maze Therapeutics Appoints Herve Hoppenot as Board Chairman	MT
03/10/25	Incyte appoints Thomas Tray as principal financial officer - SEC filing	RE
22/09/25	Incyte Announces the Appointment of Dave Gardner as Executive Vice President and Chief Strategy Officer, Effective September 22, 2025	CI
25/08/25	Incyte names Soni Basi as Executive Vice President and Chief Human Resources Officer	RE
25/08/25	Incyte Announces Executive Changes, Effective August 25, 2025	CI
07/08/25	Incyte Corp - CFO Christiana Stamoulis to step down September 16 - SEC filing	RE
05/08/25	Incyte Corporation Announces Departure of Christiana Stamoulis as Executive Vice President, Effective September 16, 2025	CI
05/08/25	Incyte Corporation Announces Departure of Christiana Stamoulis as Chief Financial Officer, Effective September 16, 2025	CI
29/07/25	Incyte's new CEO outlines growth plan as Jakafi patent cliff nears	RE
23/07/25	Incyte Insider Sold Shares Worth $251,786, According to a Recent SEC Filing	MT
07/07/25	Incyte Insider Sold Shares Worth $743,039, According to a Recent SEC Filing	MT
07/07/25	Incyte Insider Sold Shares Worth $587,275, According to a Recent SEC Filing	MT